This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n17http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n13http://linked.opendata.cz/resource/domain/vavai/projekt/
n10http://linked.opendata.cz/ontology/domain/vavai/
n14http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n12http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F68378050%3A_____%2F03%3A23033193%21RIV%2F2004%2FGA0%2FA23004%2FN/
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n16http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n18http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n7http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F68378050%3A_____%2F03%3A23033193%21RIV%2F2004%2FGA0%2FA23004%2FN
rdf:type
n10:Vysledek skos:Concept
dcterms:description
The purpose of this review is to discuss the positive results of MHC class I- tumour treatment obtained with immunomodulatory cytokines and tumour vaccines, as well as the prospects and limitations of such therapy. The purpose of this review is to discuss the positive results of MHC class I- tumour treatment obtained with immunomodulatory cytokines and tumour vaccines, as well as the prospects and limitations of such therapy.
dcterms:title
Tumour MHC class I downregulation and immunotherapy (Review). Tumour MHC class I downregulation and immunotherapy (Review).
skos:prefLabel
Tumour MHC class I downregulation and immunotherapy (Review). Tumour MHC class I downregulation and immunotherapy (Review).
skos:notation
RIV/68378050:_____/03:23033193!RIV/2004/GA0/A23004/N
n3:strany
2005;2008
n3:aktivita
n5:Z n5:P
n3:aktivity
P(GA301/01/0985), P(IAA5052203), P(NC7148), Z(AV0Z5052915)
n3:cisloPeriodika
6
n3:dodaniDat
n7:2004
n3:domaciTvurceVysledku
n17:6215319
n3:druhVysledku
n9:J
n3:duvernostUdaju
n4:S
n3:entitaPredkladatele
n12:predkladatel
n3:idSjednocenehoVysledku
631669
n3:idVysledku
RIV/68378050:_____/03:23033193
n3:jazykVysledku
n18:eng
n3:klicovaSlova
tumour vaccines; MHC class I downregulation
n3:klicoveSlovo
n16:MHC%20class%20I%20downregulation n16:tumour%20vaccines
n3:kodStatuVydavatele
GR - Řecká republika
n3:kontrolniKodProRIV
[90BAD54EC510]
n3:nazevZdroje
Oncology Reports
n3:obor
n6:FD
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
1
n3:pocetUcastnikuAkce
0
n3:pocetZahranicnichUcastnikuAkce
0
n3:projekt
n13:GA301%2F01%2F0985 n13:NC7148 n13:IAA5052203
n3:rokUplatneniVysledku
n7:2003
n3:svazekPeriodika
10
n3:tvurceVysledku
Bubeník, Jan
n3:zamer
n14:AV0Z5052915
s:issn
1021-335X
s:numberOfPages
4